University of Virginia and AstraZeneca: In search of novel cardiometabolic therapies

We are working with the University of Virginia to develop innovative treatments for cardiovascular disease. The partnership supports preclinical to clinical research projects aimed at identifying disease mechanisms and biological targets with potential to become successful and commercially viable treatments in areas of high unmet medical need.